Gina Ogilvie
Gina Ogilvie | |
---|---|
Academic background | |
Education | MSc, clinical epidemiology, 2001, University of British Columbia DrPH, 2012, UNC Gillings School of Global Public Health MD, McMaster University |
Thesis | Trends in care for HIV positive pregnant women in British Columbia, 1994-1999 (2001) |
Academic work | |
Institutions | University of British Columbia British Columbia Centre for Disease Control |
Gina Suzanne Ogilvie is a Canadian global and public health physician. She is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention, and Professor at the University of British Columbia in their School of Population and Public Health.
Early life and education
[edit]Ogilvie received her medical degree from McMaster University where she also completed a speciality in Family Medicine and a fellowship in Population Health and Primary care. Prior to this, she also earned her Masters of Science degree at the University of British Columbia (UBC) and her Doctorate in Public Health from the UNC Gillings School of Global Public Health.[1]
Career
[edit]Upon receiving her Doctorate in Public Health in 2012, Ogilvie became a senior research advisor at B.C. Women's Hospital & Health Centre and Assistant Director of the Women's Health Research Institute.[2] By 2015, she was the senior public health scientist and medical director at the British Columbia Centre for Disease Control and received a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention at UBC's School of Population and Public Health.[3][4] While continuing to work as a senior research advisor, she became the Principal Investigator for the QUEST HPV Study at the Vaccine Evaluation Center and Integrated Global Control of HPV Related Diseases and Cancer research program.[5] In recognition of her work, she was the recipient of UNC's Michael S. O’Malley Alumni Award for Publication Excellence in Cancer Population Sciences.[6]
In 2018, Ogilvie published a large-scale study titled “Effect of Screening with Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithalial Neoplasia at 48 Months,” that showed a more effective cervical cancer screening than the conventional pap smear test. In the study, her research team found that liquid-based cytology screening for HPV was the most effective option.[7] Following her study, Ogilvie received a $10 million grant from federal health minister Ginette Petitpas Taylor towards cervical cancer detection and vaccination.[8][9] She also became the recipient of the 2018 YWCA Women of Distinction Award in the category of Research & the Sciences.[10]
In 2020, Ogilvie received the University of British Columbia's Killam Research Prize in recognition of outstanding research and scholarly contributions.[11] In 2021, Ogilvie and colleague Teresa Liu-Ambrose were elected to the Canadian Academy of Health Sciences[12]
References
[edit]- ^ "Gina Ogilvie". cirnetwork.ca. Retrieved December 25, 2020.
- ^ "Dr. Gina Ogilvie joins BC Women's & WHRI". bcwomens.ca. June 1, 2015. Retrieved December 25, 2020.
- ^ "Dr. Gina Ogilvie joins SPPH as Canada Research Chair in Global Control of HPV-Related Disease and Cancer". spph.ubc.ca. 2015. Retrieved December 25, 2020.
- ^ "SPPH garners three new Canada Research Chairs, plus one renewal". spph.ubc.ca. 2015. Retrieved December 25, 2020.
- ^ "Congratulations to Dr. Gina Ogilvie for successfully securing over two million in funding from CIHR". med-vaceval.sites.olt.ubc.ca. July 22, 2015. Retrieved December 25, 2020.
- ^ "Ogilvie receives Michael S. O'Malley Alumni Award for Publication Excellence in Cancer Population Sciences". unclineberger.org. July 19, 2019. Retrieved December 25, 2020.
- ^ "HPV screening found more effective than Pap test at identifying cervical cancer". sph.unc.edu. July 25, 2018. Retrieved December 25, 2020.
- ^ Daflos, Penny (June 4, 2019). "World-renowned Vancouver doctor to oversee $20M in research funding". bc.ctvnews.ca. CTV News. Retrieved December 25, 2020.
- ^ Fayerman, Pamela (June 5, 2019). "Ottawa gives $10 million to local researchers for cervical cancer work". Vancouver Sun. Retrieved December 25, 2020.
- ^ "Dr. Christine Loock and Dr. Gina Ogilvie recipients of 2018 YWCA Women of Distinction Awards". med.ubc.ca. June 18, 2018. Retrieved December 25, 2020.
- ^ "2021 Faculty of Medicine Award Recipients". UBC Faculty of Medicine. 2021-11-01. Retrieved 2022-06-05.
- ^ "Dr. Gina Ogilvie and Dr. Teresa Liu-Ambrose elected into the Canadian Academy of Health Sciences". Women's Health Research Institute. September 14, 2021. Retrieved November 12, 2021.